Introducing Revolutionary Smart Lock Technology Globally,Crafting a Smarter,Safer Future for Your Home
LAS VEGAS,Jan. 15,2025 -- At CES 2025,Philips and Conex Intelligent Technology,the exclusive partnership in smart home industry since 2017,together introduce a series of smart locks,setting new standards for global home security and convenience. These innovations affirm Philips' commitment to safer,smarter homes worldwide.
Philips Easykey Shines at CES 2025,Leading the New Era of Smart Home Security
Philips Smart Locks: Global Reach,Local Fit
DDL902-MVP: Combines palm vein and facial recognition with 360-degree monitoring via three high-resolution cameras.
DDL505: Designed for extreme temperatures with IP66 waterproof and dustproof capabilities.
DDL611: Built for humid,rainy climates,ensuring durability with IP66 protection.
Philips Sync: Allows simultaneous unlocking of multiple doors for added convenience.
DDL801: A design and functionality masterpiece integrating Philips' latest security tech.
Award and Enhancements:
Philips' 5000 Series Palm Vein Recognition Smart Lock won the CES® 2025 Innovation Award as an 'Honoree',now upgraded with video capabilities.
About Shenzhen Conex Intelligent Technology Co.,Ltd.:
As brand license partners of Koninklijke Philips N.V.,Conex offers innovative smart home solutions in the smart lock and home security domains. Backed by exceptional customer service,Conex ensures seamless consumer experiences,delivering products that redefine home safety.
Experience Philips at CES:
Visit booth No. 52055 to explore these innovations and their integration into smart home systems.
Contact Us:
Aaron Ma – Public Relations Specialist (Global)Email: [email protected]
About Philips:
Philips,a leader in health technology,focuses on improving well-being through innovation. Based in the Netherlands,it excels in consumer products and healthcare solutions. News at www.philips.com/newscenter.
SHANGHAI,March 17,2025-- Singapore Treasure Carbon TechPte. Ltd. (SGTC) and CHCC Capital (Singapore) Pte. Ltd. have jointly launched a fund that will invest in international carbon credit assets compl
HANGZHOU,China,March 17,2025--Chance Pharmaceuticals ("Chance Pharma"),a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies,to
Six new models announced for AI-enhanced gaming,streaming,and creation with 8K visuals and optimized thermal design with triple FrostBlade 4.0 cooling fans
SHANGHAI,March 3,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors